美国 · 通讯社与实时数据 · Bloomberg
Novo CEO Doustdar 'Very Optimistic' About CagriSema
Novo Nordisk A/S Chief Executive Officer Mike Doustdar discusses the possible launch of a new obesity drug called CagriSema. "We are hopeful that we will be able to get the timely…
在 Bloomberg 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.bloomberg.com)
